TipRanks
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market
AVE
Avecho Biotechnology Limited
RESEARCH TOOLSreports
Want to see AU:AVE full AI Analyst Report?

Avecho Biotechnology Limited (AVE) Ratios

13 Followers

Avecho Biotechnology Limited Ratios

AU:AVE's free cash flow for Q2 2026 was AU$-0.18. For the 2026 fiscal year, AU:AVE's free cash flow was decreased by AU$ and operating cash flow was AU$-54.53. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.38 9.95 2.81 8.30 3.82
Quick Ratio
 5.37 9.94 2.73 8.19 3.29
Cash Ratio
 4.36 6.58 1.39 6.53 1.97
Solvency Ratio
 -0.54 -0.77 -1.72 -3.46 -2.29
Operating Cash Flow Ratio
 -2.29 1.56 -2.32 -3.77 -2.23
Short-Term Operating Cash Flow Coverage
 -43.33 0.00 -4.06 -41.34 -23.48
Net Current Asset Value
AU$ 1.66MAU$ 1.51MAU$ 3.08MAU$ 6.06MAU$ 1.93M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 <0.01 0.22 0.02 0.07
Debt-to-Equity Ratio
 0.12 <0.01 0.33 0.03 0.10
Debt-to-Capital Ratio
 0.11 <0.01 0.25 0.03 0.09
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 4.41 4.56 1.53 1.15 1.38
Debt Service Coverage Ratio
 -9.91 -8.39 -1.24 -23.48 -19.19
Interest Coverage Ratio
 -17.09 -13.01 -86.80 -298.84 -482.60
Debt to Market Cap
 <0.01 0.00 0.16 0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.82 0.79 0.44 1.64 0.58
Profitability Margins
Gross Profit Margin
53.38%60.70%59.31%-9.25%70.25%
EBIT Margin
-781.51%-485.09%-270.52%-722.41%-206.91%
EBITDA Margin
-766.00%-474.02%-257.72%-684.83%-186.54%
Operating Profit Margin
-742.55%-485.09%-437.69%-969.06%-271.39%
Pretax Profit Margin
-822.47%-518.07%-275.55%-952.80%-262.62%
Net Profit Margin
-360.19%-356.82%-275.55%-725.79%-207.44%
Continuous Operations Profit Margin
-565.21%-356.82%-275.55%-725.79%-207.44%
Net Income Per EBT
43.79%68.88%100.00%76.17%78.99%
EBT Per EBIT
110.76%106.80%62.96%98.32%96.77%
Return on Assets (ROA)
-43.57%-62.15%-62.48%-46.96%-70.00%
Return on Equity (ROE)
-211.39%-283.18%-95.48%-53.89%-96.58%
Return on Capital Employed (ROCE)
-109.59%-93.86%-150.89%-70.86%-117.84%
Return on Invested Capital (ROIC)
-74.44%-64.50%-54.30%-52.71%-88.27%
Return on Tangible Assets
-43.57%-62.15%-62.48%-46.96%-70.56%
Earnings Yield
-4.93%-15.02%-50.00%-50.51%-8.66%
Efficiency Ratios
Receivables Turnover
 0.70 0.56 0.50 0.43 1.51
Payables Turnover
 0.51 4.69 7.60 5.45 1.76
Inventory Turnover
 28.39 60.31 3.35 5.33 0.84
Fixed Asset Turnover
 4.35 36.73 6.63 1.50 2.41
Asset Turnover
 0.12 0.17 0.23 0.06 0.34
Working Capital Turnover Ratio
 0.16 0.26 0.24 0.11 0.36
Cash Conversion Cycle
 -180.68 578.31 784.57 849.07 470.06
Days of Sales Outstanding
 523.48 650.09 723.71 847.51 241.18
Days of Inventory Outstanding
 12.86 6.05 108.89 68.52 436.49
Days of Payables Outstanding
 717.01 77.83 48.03 66.96 207.60
Operating Cycle
 536.33 656.14 832.60 916.03 677.67
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 <0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 <0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.03
Dividend Paid and CapEx Coverage Ratio
 -1.74K 0.00 0.00 -635.99K -31.35
Capital Expenditure Coverage Ratio
 -1.74K 0.00 0.00 -635.99K -31.35
Operating Cash Flow Coverage Ratio
 -15.29 76.22 -3.69 -18.16 -6.77
Operating Cash Flow to Sales Ratio
 -3.42 0.89 -3.50 -6.72 -1.47
Free Cash Flow Yield
-4.50%3.75%-63.56%-46.73%-6.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -13.33 -6.43 -2.00 -1.98 -11.55
Price-to-Sales (P/S) Ratio
 75.96 23.75 5.51 14.37 23.96
Price-to-Book (P/B) Ratio
 38.99 18.85 1.91 1.07 11.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -22.20 26.65 -1.57 -2.14 -15.74
Price-to-Operating Cash Flow Ratio
 -21.38 26.65 -1.57 -2.14 -16.24
Price-to-Earnings Growth (PEG) Ratio
 0.13 -0.16 0.06 -0.13 0.37
Price-to-Fair Value
 38.99 18.85 1.91 1.07 11.15
Enterprise Value Multiple
 -9.10 -4.22 -1.69 -0.45 -12.26
Enterprise Value
 70.89M 24.75M 4.95M 1.48M 25.83M
EV to EBITDA
 -9.10 -4.22 -1.69 -0.45 -12.26
EV to Sales
 69.69 20.00 4.37 3.11 22.88
EV to Free Cash Flow
 -20.37 22.44 -1.25 -0.46 -15.03
EV to Operating Cash Flow
 -20.38 22.44 -1.25 -0.46 -15.51
Tangible Book Value Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.31 0.31 0.52 0.24 0.21
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 0.44 0.69 1.00 0.76 0.79
Interest Burden
 1.05 1.07 1.02 1.32 1.27
Research & Development to Revenue
 5.00 3.48 3.17 4.47 1.41
SG&A to Revenue
 3.02 1.97 1.80 5.13 1.32
Stock-Based Compensation to Revenue
 0.00 0.00 0.01 0.22 0.18
Income Quality
 0.95 -0.25 1.27 0.93 0.71
Currency in AUD